NCT03331770View on ClinicalTrials.gov

Efficacy and Tolerability of an Innovative Formulation of BAK-free Latanoprost

PHASE4CompletedINTERVENTIONAL

Enrollment

103

Participants

Timeline

Start Date

January 6, 2017

Primary Completion Date

October 6, 2017

Study Completion Date

October 6, 2017

Conditions

Primary Open-angle Glaucoma

Interventions

DRUG

Latanoprost Ophthalmic Product

Multidose bottle, preserved with potassium sorbate, that can be stored at room temperature up to 30°C during all shelf life, the emulsion does not require shaking before use

Trial Locations (1)

1407

Laboratoarios Poen, Buenos Aires